Nature's Sunshine’s (NASDAQ:NATR) Q3: Strong Sales

Core Insights - Nature's Sunshine (NASDAQ:NATR) exceeded Wall Street's revenue expectations in Q3 CY2025, reporting a 12% year-on-year sales increase to $128.3 million, which was 6.7% above analyst estimates [1][7][8] - The company raised its full-year revenue guidance to $478 million at the midpoint, representing a 2.3% increase over analysts' estimates [1][8] - Non-GAAP profit was reported at $0.36 per share, significantly surpassing analysts' consensus estimates [1][8] Company Overview - Nature's Sunshine began as a small operation in Utah, focusing on manufacturing and selling nutritional and personal care products [4] Revenue Growth - Over the past 12 months, Nature's Sunshine generated $474.5 million in revenue, indicating its status as a small player in the consumer staples sector [5] - The company has shown a sluggish compounded annual growth rate of 2.8% in sales over the last three years, suggesting challenges in generating demand [6] Q3 Financial Performance - The company reported adjusted EBITDA of $15 million for Q3, reflecting a 42% year-on-year growth [3][8] - Operating margin improved to 7%, up from 4.6% in the same quarter last year, while free cash flow margin increased to 13.1%, up from 6.9% [8] Future Outlook - Analysts project a modest revenue growth of 1% over the next 12 months, indicating potential demand challenges for the company's products [9]